Table 1 |
|
| Baseline characteristics | |
| Characteristic | Number (%)1 |
| Age (Years) | |
| Median | 74.5 |
| Range | 70-86 |
| Sex | |
| Male | 23 (68%) |
| Female | 11 (32%) |
| Histology | |
| Adenocarcinoma | 16 (47%) |
| Squamous | 10 (29%) |
| Poorly differentiated | 6 (18%) |
| Large cell/other | 2 (6%) |
| Stage2 | |
| IIIB | 8 (24%) |
| IV | 26 (76%) |
| ECOG Performance Status (n=32) | |
| 0 | 10 (29%) |
| 1 | 18 (53%) |
| 2 | 4 (11%) |
| Charlson Comorbidity Score (n=33) | |
| Median | 1 |
| Range | 0-7 |
| VES-13 Score (n=29) | |
| Median | 1 |
| Range | 0-8 |
| VES ≥ 3 (Frail) | 11 (38%) |
| Tumor PDGF score (n=14)3 | |
| Median | 75 |
| Range | 0-300 |
1Number(percent) unless units otherwise specified.
2American Joint Committee on Cancer, 6th ed.
3Score: Intensity of cytoplasmic staining x percent of tumor cells.
Bauman et al. BMC Cancer 2012 12:449 doi:10.1186/1471-2407-12-449
